(ZLTQ) (ZLTQ) Stock Price, News & Analysis

Company Overview

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company's product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.

Key Stats

• Today's Range: $56.48 to $56.48
• 50-Day Range: N/A
• 52-Week Range: $23.58 to $56.50
• Volume: N/A
• Average Volume: 1.53 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZLTQ Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (ZLTQ) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (ZLTQ) investors own include Clearside Biomedical (CLSD), Northwest Biotherapeutics (NWBO), Ocular Therapeutix (OCUL), Bristol-Myers Squibb (BMY), Melinta Therapeutics (MLNT), Ambarella (AMBA) and Bausch Health Companies (BHC).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:ZLTQ
• CUSIP: 98933Q10
• CIK: 1415336
• Web: www.coolsculpting.com
• Phone: +1-925-4742500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A